agomelatine (ALTO-300) — Topline data
1H 2027
Topline data remain expected in 1H 2027 for the ALTO-300 Phase 2b MDD trial and mid-2027 for the ALTO-100 Phase 2b BPD trial.Source filing
ANRO biotech catalysts & pipeline
ALTO NEUROSCIENCE INC · Data as of 2026-09-08
Upcoming catalysts
ALTO-100 — Topline data
mid-2027
Topline data remain expected in 1H 2027 for the ALTO-300 Phase 2b MDD trial and mid-2027 for the ALTO-100 Phase 2b BPD trial.Source filing
ALTO-207 — Topline data
2H 2027
2H 2027 — ALTO-207 PACE-1 (Phase 2b adjunctive TRD) trial topline dataSource filing